BEIJING, Dec. 11 Concord Medical ServicesHoldings Limited (NYSE: CCM) ("CMS" or "the Company"), operator of the largestnetwork of radiotherapy and diagnostic imaging centers in China in terms ofrevenues and the total number of centers in operation in 2008, announced todaythat its initial public offering of 12,000,000 American Depositary Shares("ADSs"), each representing three ordinary shares of the Company, was pricedat $11.00 per ADS. Net proceeds from the sale of the ADSs are approximately$119.5 million. The ADSs are expected to begin trading on the New York StockExchange on December 11, 2009 under the symbol "CCM."
The Company intends to use the proceeds from the offering to expand itsnetwork of radiotherapy and diagnostic imaging centers, to develop two newspecialty cancer hospitals, and for general corporate purposes.
Certain of the Company's shareholders have granted the underwriters a30-day option to purchase up to an additional 1,800,000 ADSs to coverover-allotments, if any.
Morgan Stanley & Co. International plc, J.P. Morgan Securities Inc. andChina International Capital Corporation Hong Kong Securities Limited acted asjoint bookrunners for the offering.
CMS's registration statement relating to these securities has beendeclared effective by the United States Securities and Exchange Commission(the "SEC"). This press release shall not constitute an offer to sell or thesolicitation of an offer to buy, nor shall there be any sale of thesesecurities in any state or other jurisdiction in which such offer,solicitation or sale would be unlawful prior to registration or qualificationunder the securities laws of any such state or jurisdiction.
The offering of these securities is made only by means of a writtenprospectus forming a part of the effective registration statement. A copy ofthe prospectus relating to the offering may be obtained by visiting EDGAR onthe SEC's web site at http://www.sec.gov ; by contacting Morgan Stanley & Coat 180 Varick Street, New York, New York 10014, attention: ProspectusDepartment, or by calling (866) 718 1649, or by [email protected]
; by contacting J.P. Morgan at J.P. MorganSecurities Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue,Edgewood, New York 11717, or by calling 1-866-803-9204; or by contacting ChinaInternational Capital Corporation at 350 Park Avenue, 28th floor, New York,New York 10022, or by calling +852 2872-2000.
About Concord Medical Services Holdings Limited
CMS operates China's largest network of radiotherapy and diagnosticimaging centers in terms of revenues and the total number of centers inoperation in 2008. Since its establishment, CMS has been committed tobuilding an extensive network of radiotherapy and diagnostic imaging centersin China that employ advanced medical technology to sustain lives and reducesuffering. Today, the Company operates a network of more than 80 centersspanning 36 cities and 21 provinces and administrative regions in China.
Safe Harbor Statement
This press release contains statements that may constitute"forward-looking" statements within the meaning of Section 27A of theSecurities Act of 1933, as amended, and Section 21E of the Securities ExchangeAct of 1934, as amended, and as defined in the U.S. Private SecuritiesLitigation Reform Act of 1995. These forward-looking statements involve anumber of risks and uncertainties that could cause actual results, performanceor achievements to be materially different from any future results,performance or achievements expressed or implied by these forward-lookingstatements. Further information regarding these and other risks is includedin the Company's filings with the SEC, including its registration statement onForm F-1, as amended from time to time. The Company does not undertake anyobligation to update any forward-looking statement as a result of newinformation, future events or otherwise, except as required under applicablelaw.For more information, please contact: Integrated Corporate Relations, Inc. In New York: Ashley M. Ammon Tel: +1-646-277-1227 In Beijing: Michael Tieu Tel: +86-10-6599-7968 Email: [email protected]
SOURCE Concord Medical Services Holdings Limited